Related Experiment Video
Updated: Nov 3, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
Angita Jain1, Nadine Norton2, Katelyn A Bruno1
1Department of Cardiovascular Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Insights
Dilated cardiomyopathy (DCM) affects males more than females. This review explores potential physiological and immunological reasons for this sex disparity in DCM.
Area of Science:
- Cardiology
- Genetics
- Immunology
Background:
- Dilated cardiomyopathy (DCM) is a major cause of heart failure, characterized by left ventricular dilation and impaired systolic function.
- Etiologies of DCM are diverse, including genetic factors, infections, inflammation, autoimmune diseases, and toxic exposures.
- Genetic variants, particularly in TTN (Titin), are implicated in 20-50% of DCM cases.
Purpose of the Study:
- To investigate sex differences in the prevalence and pathogenesis of dilated cardiomyopathy (DCM).
- To review existing literature reporting sex-specific data for idiopathic and familial/genetic DCM.
- To explore potential biological mechanisms underlying the observed male predominance in DCM.
Main Methods:
- Systematic literature search for studies reporting sex-specific data on idiopathic or familial/genetic DCM.
- Analysis of sex ratios from 31 studies on non-genetic DCM and 7 studies on familial/genetic DCM.
- Review of basic and clinical research on sex differences in physiology, immune response, and fibrosis relevant to DCM.
Main Results:
- Non-genetic DCM showed an average male to female ratio of 2.5:1.
- Familial/genetic DCM exhibited an average male to female ratio of 1.7:1.
- No studies reviewed reported a higher prevalence of DCM in females compared to males.
Conclusions:
- Males are disproportionately affected by dilated cardiomyopathy compared to females across both genetic and non-genetic forms.
- Sex-based differences in physiology, immune responses, and fibrotic processes may contribute to the increased susceptibility of males to DCM.
- Further research is warranted to elucidate the specific mechanisms driving sex disparities in DCM pathogenesis.
Abstract:
Dilated cardiomyopathy (DCM) is characterized by dilatation of the left ventricle and impaired systolic function and is the second most common cause of heart failure after coronary heart disease. The etiology of DCM is diverse including genetic pathogenic variants, infection, inflammation, autoimmune diseases, exposure to chemicals/toxins as well as endocrine and neuromuscular causes. DCM is inherited in 20-50% of cases where more than 30 genes have been implicated in the development of DCM with pathogenic variants in TTN (Titin) most frequently associated with disease. Even though male sex is a risk factor for heart failure, few studies have examined sex differences in the pathogenesis of DCM. We searched the literature for studies examining idiopathic or familial/genetic DCM that reported data by sex in order to determine the sex ratio of disease. We found 31 studies that reported data by sex for non-genetic DCM with an average overall sex ratio of 2.5:1 male to female and 7 studies for familial/genetic DCM with an overall average sex ratio of 1.7:1 male to female. No manuscripts that we found had more females than males in their studies. We describe basic and clinical research findings that may explain the increase in DCM in males over females based on sex differences in basic physiology and the immune and fibrotic response to damage caused by mutations, infections, chemotherapy agents and autoimmune responses.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Sex-linked Disorders
Cardiomyopathy IV: Restrictive Cardiomyopathy

